Background: Predisposing factors for posttraumatic stress disorder (PTSD) include experiencing a traumatic event, threat of injury or death, and untreated pain. Ketamine, an anesthetic, is used at low doses as part of a multimodal anesthetic regimen. However, since ketamine is associated with psychosomatic effects, there is a concern that ketamine may increase the risk of developing PTSD. This study investigated the prevalence of PTSD in Operation Iraqi Freedom/Operation Enduring Freedom (OIF/OEF) service members who were treated for burns in a military treatment center.
U p to 17% of returning Operation Iraqi Freedom/Operation Enduring Freedom (OIF/OEF) noninjured veterans report cognitive and psychological symptoms consistent with posttraumatic stress disorder (PTSD); however, increased levels of direct combat exposure with minor wounds or injuries correlate with higher rates of PTSD. 1 This is in contrast to recent data suggesting that among returning OIF/OEF battle injured soldiers PTSD rates are similar to those in noninjured soldiers. 2 Recent literature also points to a link between untreated pain and PTSD. [3] [4] [5] [6] Ketamine, a nonbarbiturate intravenous anesthetic regaining popularity especially within military medicine, is used at low doses as part of a multimodal approach for treating pain in burn patients at the United States Army Institute of Surgical Research (USAISR) Burn Center. However, since ketamine is associated with psychoactive effects (dissociative and psychotic states), there is concern that it may increase the likelihood of developing PTSD. This study investigates the prevalence of PTSD in OIF/OEF service members who were treated for burns in our military treatment center and also investigates the potential relationship of ketamine and PTSD prevalence.
PTSD is a psychological disorder characterized by recurrent flashbacks, nightmares, emotional disturbances, social withdrawal, and forgetfulness. It often arises after a traumatic experience in which the participant is threatened with harm or death. Predisposing factors for PTSD include experiencing a traumatic event, threat of injury or death, and threat to one's physical integrity, such as untreated pain. 7, 8 The risk of PTSD increases if the participant is physically harmed. This life changing disorder has been reported to affect almost half of the burn patient population, with civilian burn centers reporting a range of 8% to 45%. 9 -12 
METHODS
The PTSD Checklist-Military (PCL-M) is a screening tool for PTSD that is authorized for use by the US military. It consists of 17 questions rated on a scale of 1 to 5 so that a total score of 17 to 85 is possible. Initially, a score of 50 or greater was considered a positive screen for PTSD. However,
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To examine the relationship between burn size and PTSD in 241 injured OIF/OEF patients who completed the PCL-M, data were sorted into two groups based on burn size using 20% total body surface area (TBSA) burns as the cutoff point (less than 20% TBSA and 20% or greater TBSA). This cutoff was chosen because 20% TBSA is the medically accepted minimal burn size that produces both the maximal response of inflammation and the maximal hyperbolic response.
Inclusion criteria for this study required that the patient have been screened for PTSD using the PCL-M from years 2002 through 2007. After IRB approval, charts were reviewed to determine percent TBSA, injury severity score (ISS), total number of surgeries at the USAISR Burn Unit and the anesthetic regimen used, including amounts given. Using a standard opioid conversion calculator, narcotic medications were converted to IV morphine equivalents. Statistical analysis included the Mann-Whitney test for nonparametric data sets, the Spearman correlation test to determine the relationship between PTSD and other factors, and ROC analysis.
RESULTS
Of approximately 25,000 soldiers injured in OIF/OEF, 603 were burn victims treated at the USAISR Burn Center. Two hundred forty-one of these burn patients completed the PCL-M, and 147 of those screened underwent at least one operation at the USAISR. Intraoperatively, 119 received ketamine, and 28 did not receive ketamine (Fig. 1) . The increased morbidity of patients who received ketamine was evidenced by significantly higher %TBSA (21.43 vs. 10.22) and ISS (16.94 vs. 8.5) compared with those who did not receive ketamine. The ketamine group also had lengthier ICU stays (21.14 vs. 11.67 days) and more operative interventions (2.55 vs. 1.07) ( Table 1) .
Patients receiving ketamine demonstrated a lower prevalence of PTSD. Of those receiving ketamine, the prevalence of PTSD was 26.9% (32 of 119) versus 46.4% in those not receiving ketamine (13 of 28) ( p ϭ 0.044, Mann-Whitney test) ( Table 2 ). Patients receiving ketamine on average had larger burns, more severe injuries, spent more time in the ICU, and had more surgical procedures. The demographics of the ketamine receiving population (ketamine) and the non-ketamine receiving group (no ketamine) are shown in Table  1 . Based on the Mann-Whitney test for statistical significance on nonparametric data sets, all of the collected values of TBSA, ISS, ICU days, number of operations, and total morphine equivalent units during the surgical procedures were statistically significant. There were no statistical differences in the age of ketamine and nonketamine patients or in the amount of morphine per surgical procedure.
PTSD correlated with ketamine during surgical procedures (Table 3 ). Using SPSS correlation software to determine the Spearman coefficient, it was shown that PTSD correlated with ketamine, but did not correlate with morphine equivalent units during operations, size of the burn, severity of injury, days spent in ICU, or number of operations. The correlation coefficient is Ϫ0.166, meaning that ketamine usage was correlated with decreased PTSD. However, although PTSD correlated with ketamine, the correlation was weak with a receiver operating characteristic (ROC) curve of 0.569. Multiple factors other than ketamine will be required to reliably predict PTSD.
In this study population, burn size did not seem predictive of PTSD prevalence. Using the data from 241 soldiers admitted to the USAISR who completed the PCL-M, the prevalence of PTSD in the soldiers with burns less than 20% TBSA was 49 of 180 (27%), whereas soldiers with burns 20% or greater had a prevalence of PTSD of 17 of 61 (27.8%) ( Table 4 ). This is despite the fact that 20% is the medically accepted standard size of burn that produces maximal response of inflammation and the maximal hyperbolic response.
However, to determine whether there is a percent TBSA burned that would be useful to predict PTSD development, the percent TBSA burned was plotted against the prevalence of PTSD (Fig. 2) , the PTSD diagnosis (1 ϭ yes, 0 ϭ no) (data not shown), and the PCL-M score (data not shown). Best fit lines were determined and showed no significant change in slope across the spectrum of TBSA burn. This indicated that there was no standard sized burn that can be used to successfully predict PTSD development in this population.
DISCUSSION
Mechanisms to predict PTSD development are not welldeveloped. Initially, physical injury (burn size) was identified as a potential indicator of PTSD development. Recent studies have shown that PTSD does not correlate with burn size. 10, 14 This study confirms that PTSD does not correlate with burn size in OIF/OEF soldiers and suggests that burn size is not a good marker for PTSD development in these patients.
The PCL-M is a 17-question screening tool for PTSD recommended for assessment of PTSD in military populations. A score of 44 or higher is considered a positive screen for PTSD and was used in this study. 13 The prevalence of PTSD in all 241 burned soldiers screened for PTSD (28%) is similar to the prevalence found in civilian burn populations (8%-45%). 9 -12 Ketamine is used as part of a multimodal anesthetic plan that usually includes an opioid component. Ketamine decreases the amount of opioid needed to effectively control pain. Ketamine is a multifunctional drug affecting multiple receptors including NMDA receptors, opioid receptors, and monoaminergic receptors. 15 It is used in total intravenous anesthesia where it functions as both an analgesic and an anesthetic depending on plasma concentration. 15 Ketamine acts as a profound analgesic at low doses by itself, as well as potentiating the effects of opioids. Ketamine is a noncompetitive inhibitor of NMDA receptors that block Ca 2ϩ channels. 16 -18 With ketamine exposure, the NMDA receptor is not activated and does not initiate downstream signaling. Ketamine alters Ca 2ϩ , 16 cAMP, 19 protein kinase C, 20 and mitogen activated protein kinase 21 signaling.
Although ketamine is used in a multimodal anesthetic regime, it is associated with dissociative, psychotic, and psychodyslectic effects similar to those associated with PTSD. PTSD is characterized by over-stimulated brain activity. Contrary to concerns about additive effects upon brain activity and PTSD development, in this study the patients receiving ketamine during operative procedures had a lower prevalence of PTSD than soldiers receiving no ketamine during their surgeries despite having larger burns, more severe injuries based on higher ISS, undergoing more operations, and spending more time in the ICU. Soldiers receiving ketamine perioperatively also received more morphine equivalent units. However, the morphine equivalent units did not correlate with PSTD development. Our findings suggest that ketamine does not increase the prevalence of PTSD and may even decrease it. This allows ketamine to be added to the arsenal for effective pain relief.
The mediating effects of ketamine need to be examined further with known correlates of PTSD. Although traditional thinking has been to associate ketamine administration with increased incidence of PTSD, these results question that re- lationship. In fact, it seems that ketamine may decrease the prevalence of PTSD in the combat burned patient. Potential explanations of this finding could include better pain management for patients receiving ketamine, neuronal protection by ketamine, and/or antagonism of the N-methyl-D-aspartate (NMDA) receptor by ketamine. Further research studies into the role of ketamine and individual anesthetic agents as well as various anesthetic techniques may help elucidate practical perioperative approaches in decreasing the prevalence of PTSD in the combat wounded as well as the civilian population who are at risk for this devastating disorder.
CONCLUSION
Perioperative low-dose ketamine use in burned soldiers undergoing surgery seems to decrease the prevalence of PTSD. The mechanism of this is unclear but could result from better pain control, neuronal protection by ketamine, and antagonism of the NMDA receptor. Further studies are necessary that determine the mechanisms of action and additional factors that will correlate with ketamine to predict PTSD outcome.
